265 related articles for article (PubMed ID: 15959779)
1. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of two fluorouracil administration regimens for colorectal cancer.
Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
[TBL] [Abstract][Full Text] [Related]
3. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens.
Katsumata K; Tomioka H; Sumi T; Yamashita S; Takagi M; Kato F; Nakamura R; Koyanagi Y; Aoki T; Kato K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):155-60. PubMed ID: 12647017
[TBL] [Abstract][Full Text] [Related]
4. Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
Ford HE; Mitchell F; Cunningham D; Farrugia DC; Hill ME; Rees C; Calvert AH; Judson IR; Jackman AL
Clin Cancer Res; 2002 Jan; 8(1):103-9. PubMed ID: 11801545
[TBL] [Abstract][Full Text] [Related]
5. [Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Fukunaga T; Aihara N
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2077-81. PubMed ID: 14712768
[TBL] [Abstract][Full Text] [Related]
6. [Thymidylate synthase activity after preoperative administration of 5-FU in patients with gastric or colorectal cancer].
Arima S; Tachikawa D; Kawahara K; Futami K
Gan To Kagaku Ryoho; 2000 May; 27(5):703-10. PubMed ID: 10832438
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between expression of thymidylate synthase and colorectal carcinoma].
Yu ZG; Sun JZ; Zhang Q; Jia HY; Wang JX
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1432-5. PubMed ID: 15500737
[TBL] [Abstract][Full Text] [Related]
9. [Enhanced induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil its relationship to DNA ploidy pattern].
Yamane N; Makino M; Taniguchi T; Kurayoshi K; Kaibara N
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():404-9. PubMed ID: 9589043
[TBL] [Abstract][Full Text] [Related]
10. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
11. Different pathways of 5-fluorouracil metabolism after continuous venous or bolus injection in patients with colon carcinoma: possible predictive value of thymidylate synthetase mRNA and ribonucleotide reductase for 5-fluorouracil sensitivity.
Kubota T; Watanabe M; Otani Y; Kitajima M; Fukushiuma M
Anticancer Res; 2002; 22(6B):3537-40. PubMed ID: 12552952
[TBL] [Abstract][Full Text] [Related]
12. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?
Prall F; Ostwald C; Schiffmann L; Barten M
Oncol Rep; 2007 Jul; 18(1):203-9. PubMed ID: 17549369
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative treatment with 5-fluorouracil (5-FU) in gastric and colorectal cancer].
Kawaura Y; Ohmura K; Hashizume Y; Takayama K; Sakatoku M; Hirano M; Yamada T; Iwa T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):348-52. PubMed ID: 3970555
[TBL] [Abstract][Full Text] [Related]
14. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
15. [Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1053-6. PubMed ID: 15272584
[TBL] [Abstract][Full Text] [Related]
16. In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells.
Qin B; Tanaka R; Ariyama H; Shibata Y; Arita S; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):439-43. PubMed ID: 16550002
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
18. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
19. Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
Yeh KH; Yeh SH; Hsu CH; Wang TM; Ma IF; Cheng AL
Br J Cancer; 2000 Dec; 83(11):1510-5. PubMed ID: 11076661
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced colon cancer with metastases to both the Virchow's and the paraaortic lymph nodes that achieved complete long-term response with levofolinate.5-FU therapy].
Mio H; Yamada T; Sekiya M; Maruyama H; Kathou T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):423-6. PubMed ID: 15045954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]